| Phase 1 | 2 | |
| Phase 2 | 1 | |
| Phase 3 | 3 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT07424677 | Study of Saroglitazar Magnesium for PBC Patients With Incomplete Response or Intolerant… | Primary Biliary Cholangitis | Recruiting | 2026-09-15 |
| NCT07216235 | Long-Term Study to Evaluate the Safety and Efficacy in Participants With Primary Biliary… | Primary Biliary Cholangitis | Recruiting | 2026-08-04 |
| NCT06427395 | Open-Label Extension Study of Saroglitazar Magnesium in Participants With Primary Biliary… | Primary Biliary Cholangitis | Active, Not Recruiting | 2026-05-12 |
| Phase 2 | ||||
| NCT07023835 | Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral… | Amyotrophic Lateral Sclerosis (ALS) | Recruiting | 2026-09-01 |
| Phase 1 | ||||
| NCT05045482 | Hepatic Impairment With Cirrhosis Due to Cholestatic Liver Disease | Hepatic Impairment | Recruiting | 2026-09-14 |
| NCT06825559 | Evaluate PK & Safety of Saroglitazar in Subjects With Moderate Hepatic Impairment Due to… | Cholestatic Liver Disease | Recruiting | 2026-09-14 |
ALS (1)